--- title: "Mizuho Markets Americas LLC Trims Stock Holdings in Kenvue Inc. $KVUE" type: "News" locale: "en" url: "https://longbridge.com/en/news/293737854.md" description: "Mizuho Markets Americas LLC reduced its stake in Kenvue Inc. (KVUE) by 85% in Q1, selling over 12 million shares. The fund now holds approximately 2.12 million shares, representing 1.0% of its portfolio. This move contrasts with other institutions like Physician Wealth Advisors and SBI Securities, which increased their holdings in Kenvue during the fourth quarter. Kenvue recently reported strong quarterly earnings, beating estimates on both EPS and revenue." datetime: "2026-07-24T10:08:35.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/293737854.md) - [en](https://longbridge.com/en/news/293737854.md) - [zh-HK](https://longbridge.com/zh-HK/news/293737854.md) generator: "portal-rs" --- # Mizuho Markets Americas LLC Trims Stock Holdings in Kenvue Inc. $KVUE Mizuho Markets Americas LLC lowered its stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 85.0% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,123,921 shares of the company's stock after selling 12,030,014 shares during the period. Kenvue accounts for approximately 1.0% of Mizuho Markets Americas LLC's portfolio, making the stock its 28th biggest holding. Mizuho Markets Americas LLC owned 0.11% of Kenvue worth $36,616,000 at the end of the most recent reporting period. - Bullseye Bounce: Toms Capital Takes a Stake in Target Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Elyxium Wealth LLC purchased a new position in Kenvue in the 4th quarter valued at about $26,000. Physician Wealth Advisors Inc. grew its holdings in shares of Kenvue by 67.5% during the fourth quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company's stock worth $26,000 after buying an additional 618 shares in the last quarter. MV Capital Management Inc. purchased a new stake in shares of Kenvue during the fourth quarter worth about $28,000. Reflection Asset Management acquired a new position in shares of Kenvue in the fourth quarter valued at approximately $32,000. Finally, SBI Securities Co. Ltd. raised its position in shares of Kenvue by 82.4% in the fourth quarter. SBI Securities Co. Ltd. now owns 2,273 shares of the company's stock valued at $39,000 after buying an additional 1,027 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company's stock. ## Kenvue Price Performance KVUE stock opened at $18.89 on Friday. The company has a market cap of $36.28 billion, a PE ratio of 22.23, a price-to-earnings-growth ratio of 1.45 and a beta of 0.47. The company has a current ratio of 0.98, a quick ratio of 0.70 and a debt-to-equity ratio of 0.67. The stock has a 50-day moving average price of $18.33 and a two-hundred day moving average price of $17.91. Kenvue Inc. has a 12-month low of $14.02 and a 12-month high of $22.87. - Insider Buying: Smart Money Just Spent +$100M on These 3 Stocks Kenvue (NYSE:KVUE - Get Free Report) last released its quarterly earnings data on Thursday, May 7th. The company reported $0.32 EPS for the quarter, topping analysts' consensus estimates of $0.27 by $0.05. The company had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $3.84 billion. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The company's quarterly revenue was up 4.5% compared to the same quarter last year. During the same period last year, the business posted $0.24 EPS. As a group, research analysts predict that Kenvue Inc. will post 1.16 EPS for the current year. ## Kenvue Dividend Announcement The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 27th. Investors of record on Wednesday, May 13th were issued a $0.2075 dividend. The ex-dividend date was Wednesday, May 13th. This represents a $0.83 annualized dividend and a yield of 4.4%. Kenvue's dividend payout ratio (DPR) is presently 97.65%. ## Wall Street Analysts Forecast Growth - 3 Smart Defensive Stocks for an Uneasy Market A number of analysts recently issued reports on KVUE shares. Citigroup decreased their target price on shares of Kenvue from $20.00 to $19.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 15th. Wall Street Zen raised Kenvue to a "buy" rating in a research note on Sunday, July 12th. UBS Group raised their price objective on Kenvue from $18.00 to $20.00 and gave the stock a "neutral" rating in a report on Thursday, July 16th. Barclays lifted their price objective on Kenvue from $18.00 to $19.00 and gave the company an "equal weight" rating in a research report on Tuesday. Finally, Zacks Research lowered Kenvue from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, July 7th. Three analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $19.58. **View Our Latest Stock Report on Kenvue** ## Insider Buying and Selling In other Kenvue news, General Counsel Matthew Orlando sold 38,491 shares of Kenvue stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $17.66, for a total transaction of $679,751.06. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders own 1.59% of the company's stock. ## Kenvue Company Profile (Free Report) Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines. The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels. ## Further Reading - Five stocks we like better than Kenvue - Premium Retail’s Stress Test Is Separating Winners From Losers - D-Wave Quantum or a Quantum ETF: Which Is the Better Bet? - GE Vernova Just Sent a Mixed AI Signal to Investors - Alphabet Crushed Earnings, But One Number Spooked the Market *This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.* ## Should You Invest $1,000 in Kenvue Right Now? Before you consider Kenvue, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kenvue wasn't on the list. While Kenvue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [KVUE.US](https://longbridge.com/en/quote/KVUE.US.md) - [MFG.US](https://longbridge.com/en/quote/MFG.US.md) - [8411.JP](https://longbridge.com/en/quote/8411.JP.md) - [8473.JP](https://longbridge.com/en/quote/8473.JP.md) - [TGT.US](https://longbridge.com/en/quote/TGT.US.md) - [C.US](https://longbridge.com/en/quote/C.US.md) - [UBS.US](https://longbridge.com/en/quote/UBS.US.md) - [BCS.US](https://longbridge.com/en/quote/BCS.US.md) - [C-R.US](https://longbridge.com/en/quote/C-R.US.md) - [BARC.UK](https://longbridge.com/en/quote/BARC.UK.md) ## Related News & Research - [Australia clears Kimberly-Clark's acquisition of Kenvue but requires Carefree, Stayfree divestment](https://longbridge.com/en/news/297715438.md) - [Kenvue says Kenvue Cares Week volunteer program logs 7,750 hours in 2026 Healthy Lives Mission report](https://longbridge.com/en/news/297065612.md) - [Mundoro Capital Inc. GAAP EPS of $0.00](https://longbridge.com/en/news/297553342.md) - [TenX Protocols Inc. reports Q1 results](https://longbridge.com/en/news/297560433.md) - [Cheelcare Inc. GAAP EPS of $0.27, revenue of $1.9M](https://longbridge.com/en/news/297552713.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**